129 related articles for article (PubMed ID: 20170928)
1. Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.
Kang HE; Sohn SI; Baek SR; Lee JW; Lee MG
Metabolism; 2010 Oct; 59(10):1472-80. PubMed ID: 20170928
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats with acute hepatitis induced by d-galactosamine/lipopolysaccharide or CCl(4).
Kang HE; Kim YW; Sohn SI; Baek SR; Lee JW; Kim SG; Lee I; Lee MG
Xenobiotica; 2010 Jun; 40(6):424-36. PubMed ID: 20350053
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats.
Kang HE; Sohn SI; Baek SR; Lee JW; Lee MG
J Pharm Pharmacol; 2011 Jan; 63(1):49-57. PubMed ID: 21155815
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction between liquiritigenin (LQ) and DDB: increased glucuronidation of LQ in the liver possibly due to increased hepatic blood flow rate by DDB.
Kang HE; Chung HJ; Kim HS; Lee JW; Lee MG
Eur J Pharm Sci; 2010 Jan; 39(1-3):181-9. PubMed ID: 19961930
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin.
Lee DY; Chung HJ; Choi YH; Lee U; Kim SH; Lee I; Lee MG
Eur J Pharm Sci; 2009 Dec; 38(5):465-71. PubMed ID: 19761842
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
Kim YC; Lee AK; Lee JH; Lee I; Lee DC; Kim SH; Kim SG; Lee MG
Eur J Pharm Sci; 2005 Sep; 26(1):114-23. PubMed ID: 15985363
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.
Lee YS; Choi YH; Kim TK; Ryu KH; Lee BY; Lee MG
Xenobiotica; 2010 Feb; 40(2):129-37. PubMed ID: 19929308
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
Bae SK; Yang SH; Lee SJ; Kwon JW; Kim WB; Lee DC; Lee MG
Eur J Pharm Sci; 2005 Jun; 25(2-3):337-45. PubMed ID: 15911231
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.
Kim YC; Kang HE; Lee MG
Biopharm Drug Dispos; 2008 Jan; 29(1):51-61. PubMed ID: 18022993
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect.
Kang HE; Cho YK; Jung HY; Choi KY; Sohn SI; Baek SR; Lee MG
Xenobiotica; 2009 Jun; 39(6):465-75. PubMed ID: 19480552
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of isoliquiritigenin and its metabolites in rats: low bioavailability is primarily due to the hepatic and intestinal metabolism.
Lee YK; Chin YW; Bae JK; Seo JS; Choi YH
Planta Med; 2013 Nov; 79(17):1656-65. PubMed ID: 24108436
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats.
Lee JH; Lee A; Oh JH; Lee YJ
Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin.
Choi YH; Lee AK; Bae SK; Kim SO; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):93-8. PubMed ID: 15674819
[TBL] [Abstract][Full Text] [Related]
15. Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin.
Lee JH; Lee MG
Pharm Res; 2008 Aug; 25(8):1915-24. PubMed ID: 18478316
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
Song Y; Yang X; Jiang Y; Tu P
J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
[TBL] [Abstract][Full Text] [Related]
17. Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin.
Choi YH; Lee DC; Lee I; Lee MG
J Pharm Sci; 2008 Dec; 97(12):5363-75. PubMed ID: 18393297
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
Lau YY; Okochi H; Huang Y; Benet LZ
Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
[TBL] [Abstract][Full Text] [Related]
19. Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine.
Kim YW; Ki SH; Lee JR; Lee SJ; Kim CW; Kim SC; Kim SG
Chem Biol Interact; 2006 Jun; 161(2):125-38. PubMed ID: 16647697
[TBL] [Abstract][Full Text] [Related]
20. Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes.
Kim YW; Kang HE; Lee MG; Hwang SJ; Kim SC; Lee CH; Kim SG
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G372-81. PubMed ID: 19074639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
